Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Srinivas

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|December 13, 2016
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trialArjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, et al.
The Lancet. Oncology|March 5, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort studyNieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Prostate cancer, version 2.2014James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJames L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2023
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in OncologyEdward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2026
NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026Daniel E Spratt, Sandy Srinivas, Nabil Adra, et al.
European Urology Focus|July 30, 2017
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based AnalysisAndrea Necchi, Luigi Mariani, Salvatore Lo Vullo, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1E David Crawford, Alan H Bryce, Maha H Hussain, et al.
Nature|April 16, 2025
An ultrasensitive method for detection of cell-free RNAMonica C Nesselbush, Bogdan A Luca, Young-Jun Jeon, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|December 13, 2016
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trialArjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, et al.
The Lancet. Oncology|March 5, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort studyNieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Prostate cancer, version 2.2014James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJames L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2023
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in OncologyEdward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2026
NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026Daniel E Spratt, Sandy Srinivas, Nabil Adra, et al.
European Urology Focus|July 30, 2017
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based AnalysisAndrea Necchi, Luigi Mariani, Salvatore Lo Vullo, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1E David Crawford, Alan H Bryce, Maha H Hussain, et al.
Nature|April 16, 2025
An ultrasensitive method for detection of cell-free RNAMonica C Nesselbush, Bogdan A Luca, Young-Jun Jeon, et al.
Pageof 16